Skip to main content

Table 2 Disease-free survival by clinical and disease characteristics

From: Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies

Factor Progressors/Total 3-y DFS (%) p-value
T-stage    0.99
T1-2 6/14 69  
T3-4 5/10 56  
Lymph Node Mets    0.14
N0/N1 2/8 86  
N2 9/16 49  
Tumor Grade    0.61
Low 3/5 53  
High 8/19 64  
Perineural Inv.    0.29
Absent 4/11 70  
Present 7/13 55  
Age    0.86
< 55 4/9 50  
> 55 7/15 71  
Gender    0.28
Male 6/16 72  
Female 5/8 44  
Dose > 63 Gy    0.81
Yes 6/15 63  
No 5/9 50  
TFHX    0.17
Yes 3/12 80  
No 8/12 45